©2026 Incunabulum LLC. All rights reserved. mg Magazine is a registered trademark of Incunabulum LLC. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with prior written permission.
Tag: Iris Bincovich
Innocan Pharma Reports First Quarter 2024 Results
HERZLIYA, Israel, and CALGARY, AB -- Innocan Pharma Corporation, a pharmaceutical technology company focusing on developing innovative drug delivery platform technologies, is pleased to announce...
FDA Grants Innocan Pharma Meeting Date for LPT-CBD for Chronic Pain
HERZLIYA, Israel, and CALGARY, AB -- Innocan Pharma Corporation is pleased to announce significant advancements in the regulatory process for its Liposome-Cannabidiol (LPT-CBD) technology, which provides...
Innocan Pharma Reports Breakthrough in a Pre-Clinical Trial
HERZLIYA, Israel, and ALGARY, AB -- Innocan Pharma Corporation, a pioneer in the pharmaceutical and biotechnology industries, conducted a successful pre-clinical treatment with a liposomal-CBD...
Innocan Pharma Reports Full Year 2023 Results
HERZLIYA, Israel, and CALGARY, Alberta -- Innocan Pharma Corporation, a pharmaceutical technology company focusing on developing innovative drug delivery platform technologies is pleased to announce...
Innocan Pharma Closes Private Placement for Gross Proceeds of Approximately C$2 Million
HERZLIYA, Israel, and CALGARY, Alberta -- Innocan Pharma Corporation closed its previously announced non-brokered private placement offering of units of the Company, pursuant to which the...
Innocan Pharma Reports Q3 2023 Results
HERZLIYA, Israel, and CALGARY, Alberta -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTC: INNPF), a pharmaceutical technology company focusing on developing innovative drug delivery...
Innocan Pharma Unveils Groundbreaking Veterinary Breakthroughs at EAVPT 2023 Congress
HERZLIYA, Israel and CALGARY, Alberta --
Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF), a leading innovator in pharmaceutical solutions for Human & Animal...
InnoCan Pharma Submits New Patent Applications for Advanced Pain Relief Technology
HERZLIYA, Israel and CALGARY, Alberta --
InnoCan Pharma Corporation (CSE:INNO) ("Innocan Pharma" or the "Company"), a pharmaceutical technology company leveraging its novel cannabis-based therapeutics portfolio of targeted...
Innocan Reports Novel Cannabinoid Delivery Platform Patent Application
HERZLIYA, Israel and CALGARY, AB --
Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) (the "Company" or "Innocan"), a leading pharmaceutical technology company specializing...